Aclarion receives U.S. patent on expanded applications of MRS data processing
Aclarion (ACON) has received a Notice of Allowance from the United States Patent and Trademark Office for its 24th issued US patent. Whereas ...
Aclarion Wins Patent, Shares Eke Up
Aclarion, Inc. (NASDAQ: ACON) shares cleared breakeven Tuesday, as the health-care technology company announced it has received a Notice of Allowance from the United States Patent and Trademark Office ...
Aclarion secures patent for infection, pain biomarker detection
BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company, announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent ...
The Globe and Mail6d
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
CLARITY is a randomized study designed to demonstrate Nociscan’s ability to improve surgical outcomes while reducing costs for chronic low back pain Nociscan aims to become the gold standard in ...
Aclarion stock hits 52-week low at $4.41 amid steep annual decline
In a challenging year for Aclarion, the medical technology company's stock has plummeted to a 52-week low, trading at $4.41. According to InvestingPro data, the company maintains a healthy liquidity ...
Yahoo Finance2d
Aclarion, Inc. (ACON)
After hours: 7:59:08 p.m. EST ...
Yahoo Finance4d
Aclarion, Inc. (ACON)
Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.